Pharmazeutische Zeitung
The SURMOUNT-4 trial showed that 82.5% of participants who stopped tirzepatide regained at least 25% of their lost weight within one year
After addition of BSS PLUS Part II to the Part I bottle, each mL of the reconstituted product contains: sodium chloride 7.14 mg, potassium chloride 0.38 mg, calcium chloride dihydrate 0.154 mg, magnesium chloride hexahydrate 0.2 mg, dibasic sodium phosphate 0.42 mg, sodium bicarbonate 2.1 mg, dextrose 0.92 mg, glutathione disulfide (oxidized glutathione) 0.184 mg, hydrochloric acid and/or sodium hydroxide (to adjust pH), in water for injection
Recognizing Signs of Interaction Symptoms to Watch For Patients should stay alert to signs of drug interactions, including persistent nausea, dizziness, fluctuating blood sugar levels, and worsening digestive symptoms